logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

On April 2nd, Kuaishou-W (01024) spent 49.3875 million Hong Kong dollars to repurchase 1.1 million shares.

date
19:39 02/04/2026
avatar
GMT Eight
Kuaishou-W (01024) issued an announcement on April 2, 2026, stating that the company will spend 49.3875 million Hong Kong dollars to repurchase 1.1 million shares.
KUAISHOU-W (01024) announced on April 2, 2026, that the company will spend 49.3875 million Hong Kong dollars to buy back 1.1 million shares.
Related Articles
HK Stock
China Sanjiang (02198): Sanjiang Chemical and Blue Whale Bio-energy signed a naphtha purchase agreement.
HK Stock
ZERO2IPO (01945) spent HK$123,500 to repurchase 74,400 shares on April 2nd.
HK Stock
Peg Bio-Pharmaceuticals-B (02565): CR059 selected as a breakthrough in the latest abstract of the ADA 2026 Annual Meeting, innovative strength recognized again.
China Sanjiang (02198): Sanjiang Chemical and Blue Whale Bio-energy signed a naphtha purchase agreement.
HK Stock
ZERO2IPO (01945) spent HK$123,500 to repurchase 74,400 shares on April 2nd.
HK Stock
Peg Bio-Pharmaceuticals-B (02565): CR059 selected as a breakthrough in the latest abstract of the ADA 2026 Annual Meeting, innovative strength recognized again.
HK Stock
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
icon
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
icon
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
icon
02/04/2026
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.